| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
45,766,000 |
| Market
Cap: |
994.95(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$6.29 - $33.79 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8 |
| Insider 6 Months : 8 |
| Insider 3/6 Months : 16.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. Co.'s product portfolio are: ENROUTE Transcarotid Neuroprotection System, which is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, which is a self-expanding, self-tapering stent that conforms to patient; ENHANCE Transcarotid Peripheral Access Kit, which is used in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire, which is used for navigating and crossing the target lesion for delivery of interventional devices.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
11,700 |
11,700 |
11,700 |
11,700 |
| Total Buy Value |
$198,783 |
$198,783 |
$198,783 |
$198,783 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
24,257 |
27,257 |
40,770 |
602,067 |
| Total Sell Value |
$416,468 |
$483,218 |
$770,629 |
$28,445,866 |
| Total People Sold |
5 |
5 |
6 |
8 |
| Total Sell Transactions |
5 |
6 |
13 |
58 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rogers Erica J. |
President and CEO |
• • – |
2020-06-11 |
4 |
AS |
$37.29 |
$747,441 |
D/D |
(20,044) |
110,921 |
|
72% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2020-06-11 |
4 |
OE |
$1.38 |
$27,661 |
D/D |
20,044 |
130,965 |
|
- |
|
| Davis Andrew S. |
EVPGlobal Sales& Marketing |
• – – |
2020-06-01 |
4 |
AS |
$38.67 |
$256,604 |
D/D |
(6,635) |
18,215 |
|
71% |
|
| Davis Andrew S. |
EVPGlobal Sales& Marketing |
• – – |
2020-06-01 |
4 |
OE |
$1.46 |
$9,687 |
D/D |
6,635 |
24,850 |
|
- |
|
| Buchanan Lucas W. |
Chief Financial Officer |
• – – |
2020-05-20 |
4 |
A |
$30.91 |
$18,484 |
D/D |
598 |
110,956 |
|
- |
|
| Rogers Erica J. |
President and CEO |
• • – |
2020-05-20 |
4 |
A |
$30.91 |
$21,235 |
D/D |
687 |
111,608 |
|
- |
|
| Davis Andrew S. |
EVPGlobal Sales& Marketing |
• – – |
2020-05-20 |
4 |
A |
$30.91 |
$21,235 |
D/D |
687 |
18,902 |
|
- |
|
| Buchanan Lucas W. |
Chief Financial Officer |
• – – |
2020-05-15 |
4 |
AS |
$38.61 |
$370,622 |
D/D |
(9,600) |
110,358 |
|
80% |
|
| Buchanan Lucas W. |
Chief Financial Officer |
• – – |
2020-05-15 |
4 |
OE |
$1.60 |
$15,360 |
D/D |
9,600 |
119,958 |
|
- |
|
| Rogers Erica J. |
President and CEO |
• • – |
2020-05-11 |
4 |
AS |
$37.63 |
$754,250 |
D/D |
(20,044) |
110,921 |
|
78% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2020-05-11 |
4 |
OE |
$1.38 |
$27,661 |
D/D |
20,044 |
130,107 |
|
- |
|
| Warburg Pincus Llc |
10% Owner |
– – • |
2020-05-05 |
4 |
S |
$39.00 |
$190,518,042 |
D/D |
(4,885,078) |
1,021,223 |
|
-59% |
|
| Warburg Pincus Partners Gp Llc |
10% Owner |
– – • |
2020-05-05 |
4 |
S |
$39.00 |
$190,518,042 |
D/D |
(4,885,078) |
1,021,223 |
|
-59% |
|
| Davis Andrew S. |
EVPGlobal Sales& Marketing |
• – – |
2020-05-01 |
4 |
AS |
$41.03 |
$544,475 |
D/D |
(13,270) |
18,215 |
|
46% |
|
| Davis Andrew S. |
EVPGlobal Sales& Marketing |
• – – |
2020-05-01 |
4 |
OE |
$1.46 |
$19,374 |
D/D |
13,270 |
31,485 |
|
- |
|
| Buchanan Lucas W. |
Chief Financial Officer |
• – – |
2020-04-15 |
4 |
AS |
$33.67 |
$643,009 |
D/D |
(19,100) |
110,358 |
|
59% |
|
| Buchanan Lucas W. |
Chief Financial Officer |
• – – |
2020-04-15 |
4 |
OE |
$1.60 |
$30,560 |
D/D |
19,100 |
129,458 |
|
- |
|
| Rogers Erica J. |
President and CEO |
• • – |
2020-04-14 |
4 |
AS |
$35.00 |
$96,040 |
D/D |
(2,744) |
110,921 |
|
50% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2020-04-14 |
4 |
OE |
$1.38 |
$3,787 |
D/D |
2,744 |
113,665 |
|
- |
|
| Rogers Erica J. |
President and CEO |
• • – |
2020-04-13 |
4 |
AS |
$35.02 |
$605,808 |
D/D |
(17,300) |
110,921 |
|
55% |
|
| Rogers Erica J. |
President and CEO |
• • – |
2020-04-13 |
4 |
OE |
$1.38 |
$23,874 |
D/D |
17,300 |
128,221 |
|
- |
|
| Buchanan Lucas W. |
Chief Financial Officer |
• – – |
2020-04-01 |
4 |
OE |
$1.46 |
$25,000 |
D/D |
16,273 |
110,358 |
|
- |
|
| Ruedy Richard |
EVPClin&Reg.Affairs&QA |
• – – |
2020-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
3,350 |
19,144 |
|
- |
|
| Rogers Erica J. |
President and CEO |
• • – |
2020-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
13,375 |
110,921 |
|
- |
|
| Davis Andrew S. |
EVPGlobal Sales& Marketing |
• – – |
2020-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,675 |
18,215 |
|
- |
|
410 Records found
|
|
Page 13 of 17 |
|
|
1.16 (5.64%) 
